- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
迄今为止，共66家主力机构，持仓量总计4.68亿股，占流通A股32.16%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为42.42元，股价在成本上方运行。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为42.42元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"42.42","date":1590308049,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑输行业平均水平。
[{"date":"2020.05.25","stock":"3.03","trade":"0.92","ind":"-0.11"},{"date":"2020.05.22","stock":"-3.82","trade":"-2.19","ind":"-2.22"},{"date":"2020.05.21","stock":"2.12","trade":"-0.10","ind":"-0.94"},{"date":"2020.05.20","stock":"-3.51","trade":"-0.83","ind":"-0.94"},{"date":"2020.05.19","stock":"0.09","trade":"2.02","ind":"1.21"},{"date":"2020.05.18","stock":"1.97","trade":"0.30","ind":"-0.40"},{"date":"2020.05.15","stock":"0.16","trade":"-0.09","ind":"0.02"},{"date":"2020.05.14","stock":"0.69","trade":"-0.28","ind":"-1.02"},{"date":"2020.05.13","stock":"-0.26","trade":"1.11","ind":"0.54"},{"date":"2020.05.12","stock":"-0.45","trade":"1.28","ind":"0.42"},{"date":"2020.05.11","stock":"0.00","trade":"0.29","ind":"-0.29"},{"date":"2020.05.08","stock":"1.28","trade":"0.73","ind":"1.27"},{"date":"2020.05.07","stock":"0.77","trade":"0.23","ind":"-0.18"},{"date":"2020.05.06","stock":"3.11","trade":"1.16","ind":"1.51"},{"date":"2020.04.30","stock":"-3.23","trade":"0.68","ind":"1.97"},{"date":"2020.04.29","stock":"-0.36","trade":"-1.47","ind":"0.12"},{"date":"2020.04.28","stock":"0.48","trade":"-2.52","ind":"0.47"},{"date":"2020.04.27","stock":"7.21","trade":"0.51","ind":"0.28"},{"date":"2020.04.24","stock":"-2.11","trade":"-2.74","ind":"-1.33"},{"date":"2020.04.23","stock":"4.85","trade":"2.18","ind":"-0.50"},{"date":"2020.04.22","stock":"0.69","trade":"1.16","ind":"1.05"}]
沃森生物,深证成指,生物制品指数
压力支撑
该股压力位为41.67元，支撑位为40.26元。
[{"text":"\u538b\u529b\u4f4d","value":"41.67","date":1590336000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"40.26","date":1590336000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.1资金面打败了29%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月25日 20:30
| 机构今日流向(万元) | 1325.06 | 机构5日流向(万元) | -5235.90 |
| 机构10日流向(万元) | -3245.38 | 机构20日流向(万元) | -18295.79 |
机构持仓
2020-03-31 与 2019-12-31 相比，主力机构持仓量减少545.31万股，其中基金净增仓3家，主力净减仓187家，暂未发现中长期投资价值。
截止2020-03-31，共66家主力机构（基金59家，信托公司1家，社保基金1家，一般法人5家），持仓量总计46770.8万股，占流通A股32.16%
其中，基金持仓与2019-12-31相比：
增仓：26家 ，增持 1340.94万股
减仓：23家 ，减持 133.39万股
新出现在主力名单中：10家 ，持有2936.66万股
从主力名单中消失：197家 ，原持有4575.12万股
其中，基金持仓与2019-12-31相比：
增仓：26家 ，增持 1340.94万股
减仓：23家 ，减持 133.39万股
新出现在主力名单中：10家 ，持有2936.66万股
从主力名单中消失：197家 ，原持有4575.12万股
消息面诊股
诊断结果：5.4消息面打败了35%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 药企销售费用率最高达2203%！十个10亿+注射剂
2020-05-25 - 沃森生物14:30大单揭秘:主动大单买入98912
2020-05-25 - 沃森生物10:30大单揭秘:主动大单买入51497
2020-05-25 - 【医药】公共卫生能力建设方案落地 有哪些受益方向？
2020-05-25 - 沃森生物:2020-05-22融资融券余额减238
2020-05-25 - 重磅！中国疫苗全球领跑！世界首个人体临床数据公布：
2020-05-23 - 1088万支HPV疫苗背后：有人“一针难求” 有人
2020-05-23 - 首针国产PCV13“520”开打 沃森生物近百万支
2020-05-22 - 沃森生物(05月22日)现大宗交易
2020-05-22 - 沃森生物10:30大单揭秘:主动大单卖出26014
2020-05-22
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2020-05-13 |
| 一般消息 | 高管变动 | 因个人工作变动原因 | 2020-04-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-04-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-04-16 |
| 一般消息 | 募资投向 | 2020-03-24 | |
| 利空 | 业绩预告 | 业绩预亏 | 2020-03-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-03-21 |
| 一般消息 | 募资投向 | 公司购买资产 | 2020-03-21 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2020-01-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2019-12-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2019-08-24 |
| 一般消息 | 重大事项 | 关联交易 | 2019-08-24 |
| 一般消息 | 高管变动 | 因任期届满 | 2019-08-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2019-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 1条 | 1条 |
行业面诊股
诊断结果：7.3行业面打败了96%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2020.05.25","price":"-0.11","value":"0.92"},{"date":"2020.05.22","price":"-2.22","value":"-2.19"},{"date":"2020.05.21","price":"-0.94","value":"-0.10"},{"date":"2020.05.20","price":"-0.94","value":"-0.83"},{"date":"2020.05.19","price":"1.21","value":"2.02"},{"date":"2020.05.18","price":"-0.40","value":"0.30"},{"date":"2020.05.15","price":"0.02","value":"-0.09"},{"date":"2020.05.14","price":"-1.02","value":"-0.28"},{"date":"2020.05.13","price":"0.54","value":"1.11"},{"date":"2020.05.12","price":"0.42","value":"1.28"},{"date":"2020.05.11","price":"-0.29","value":"0.29"},{"date":"2020.05.08","price":"1.27","value":"0.73"},{"date":"2020.05.07","price":"-0.18","value":"0.23"},{"date":"2020.05.06","price":"1.51","value":"1.16"},{"date":"2020.04.30","price":"1.97","value":"0.68"},{"date":"2020.04.29","price":"0.12","value":"-1.47"},{"date":"2020.04.28","price":"0.47","value":"-2.52"},{"date":"2020.04.27","price":"0.28","value":"0.51"},{"date":"2020.04.24","price":"-1.33","value":"-2.74"},{"date":"2020.04.23","price":"-0.50","value":"2.18"},{"date":"2020.04.22","price":"1.05","value":"1.16"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 双林生物 | 49.39% | 16.01% | 6.7分 |
| 2 | 通化东宝 | 34.94% | 10.89% | 7.3分 |
| 3 | 安科生物 | 28.37% | -4.35% | 6.2分 |
| 4 | 赛升药业 | 20.06% | 0.71% | 5.5分 |
| 5 | 未名医药 | 17.66% | -4.68% | 4.4分 |
| 6 | 我武生物 | 15.84% | -0.65% | 5.8分 |
| 8 | 沃森生物 | 11.96% | -2.28% | 4.9分 |
| 10 | 长春高新 | 10.77% | -1.51% | 5.7分 |
| 12 | 特宝生物 | 8.97% | -3.41% | 5.8分 |
| 14 | 卫光生物 | 5.03% | 9.35% | 6.9分 |
| 16 | 智飞生物 | 2.89% | -2.25% | 6.3分 |
| 18 | *ST生物 | 1.78% | 2.91% | 6.5分 |
| 20 | 博雅生物 | -0.72% | -2.04% | 6.2分 |
| 22 | 万泽股份 | -5.73% | -2.79% | 6.4分 |
| 24 | 常山药业 | -6.65% | -2.63% | 4.4分 |
| 26 | 海特生物 | -9.97% | -1.04% | 4.1分 |
| 28 | 康辰药业 | -10.66% | -1.89% | 5.3分 |
| 30 | 东宝生物 | -13.44% | -4.71% | 4.6分 |
| 32 | 复星医药 | -15.53% | -4.80% | 4.2分 |
| 34 | *ST交昂 | -21.60% | 2.32% | 5.5分 |
| 36 | 金花股份 | -26.92% | -7.13% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2020-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/103 ， 20/103。
[{"date":"2020-03-31","value":"-0.37","vol":"1.25"},{"date":"2019-12-31","value":"3.01","vol":"18.73"},{"date":"2019-09-30","value":"2.56","vol":"5.44"},{"date":"2019-06-30","value":"1.82","vol":"3.31"},{"date":"2019-03-31","value":"0.84","vol":"0.96"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.37 | 3.01 | 2.56 | 1.82 | 0.84 |
| 行业(%) | 1.25 | 18.73 | 5.44 | 3.31 | 0.96 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"65.19","vol":"64.26"},{"date":"2019-12-31","value":"79.75","vol":"66.09"},{"date":"2019-09-30","value":"79.67","vol":"66.62"},{"date":"2019-06-30","value":"78.79","vol":"63.96"},{"date":"2019-03-31","value":"76.09","vol":"63.78"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
65.19 | 79.75 | 79.67 | 78.79 | 76.09 |
| 行业(%) | 64.26 | 66.09 | 66.62 | 63.96 | 63.78 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 29/103 ， 34/103。
[{"date":"2020-03-31","value":"-36.34","vol":"-7.56"},{"date":"2019-12-31","value":"27.55","vol":"14.62"},{"date":"2019-09-30","value":"39.09","vol":"16.65"},{"date":"2019-06-30","value":"33.62","vol":"13.75"},{"date":"2019-03-31","value":"49.72","vol":"15.08"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-36.34 | 27.55 | 39.09 | 33.62 | 49.72 |
| 行业(%) | -7.56 | 14.62 | 16.65 | 13.75 | 15.08 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"-146.78","vol":"93.83"},{"date":"2019-12-31","value":"-86.43","vol":"36.26"},{"date":"2019-09-30","value":"32.10","vol":"265.92"},{"date":"2019-06-30","value":"16.09","vol":"-1.25"},{"date":"2019-03-31","value":"63.03","vol":"-2.76"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-146.78 | -86.43 | 32.10 | 16.09 | 63.03 |
| 行业(%) | 93.83 | 36.26 | 265.92 | -1.25 | -2.76 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 35/103 ， 31/103。
[{"date":"2020-03-31","value":"0.02","vol":"0.08"},{"date":"2019-12-31","value":"0.16","vol":"0.45"},{"date":"2019-09-30","value":"0.11","vol":"0.33"},{"date":"2019-06-30","value":"0.07","vol":"0.21"},{"date":"2019-03-31","value":"0.02","vol":"0.09"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.02 | 0.16 | 0.11 | 0.07 | 0.02 |
| 行业(次) | 0.08 | 0.45 | 0.33 | 0.21 | 0.09 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.11","vol":"0.32"},{"date":"2019-12-31","value":"0.83","vol":"1.77"},{"date":"2019-09-30","value":"0.61","vol":"1.27"},{"date":"2019-06-30","value":"0.42","vol":"0.86"},{"date":"2019-03-31","value":"0.17","vol":"0.38"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.11 | 0.83 | 0.61 | 0.42 | 0.17 |
| 行业(次) | 0.32 | 1.77 | 1.27 | 0.86 | 0.38 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-03-31","value":"-47.13","vol":"-19.89"},{"date":"2019-12-31","value":"2.13","vol":"28.09"},{"date":"2019-09-30","value":"38.04","vol":"-483.71"},{"date":"2019-06-30","value":"-16.66","vol":"16.14"},{"date":"2019-03-31","value":"-2.15","vol":"2.31"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -47.13 | 2.13 | 38.04 | -16.66 | -2.15 |
| 行业 | -19.89 | 28.09 | -483.71 | 16.14 | 2.31 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"","vol":"0.00"},{"date":"2019-12-31","value":"4.28","vol":"3.01"},{"date":"2019-09-30","value":"","vol":"0.03"},{"date":"2019-06-30","value":"2.81","vol":"3.15"},{"date":"2019-03-31","value":"","vol":"0.26"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 4.28 | - | 2.81 | - |
| 行业 | 0.00 | 3.01 | 0.03 | 3.15 | 0.26 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 18/103 ， 21/103。
[{"date":"2020-03-31","value":"3.21","vol":"5.47"},{"date":"2019-12-31","value":"3.16","vol":"4.79"},{"date":"2019-09-30","value":"3.06","vol":"4.92"},{"date":"2019-06-30","value":"3.07","vol":"4.58"},{"date":"2019-03-31","value":"2.71","vol":"4.79"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.21 | 3.16 | 3.06 | 3.07 | 2.71 |
| 行业 | 5.47 | 4.79 | 4.92 | 4.58 | 4.79 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"2.79","vol":"4.08"},{"date":"2019-12-31","value":"2.85","vol":"3.49"},{"date":"2019-09-30","value":"2.79","vol":"3.05"},{"date":"2019-06-30","value":"2.82","vol":"2.89"},{"date":"2019-03-31","value":"2.50","vol":"3.03"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.79 | 2.85 | 2.79 | 2.82 | 2.50 |
| 行业 | 4.08 | 3.49 | 3.05 | 2.89 | 3.03 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 24/103 ， 21/103。
[{"date":"2020-03-31","value":"18.64","vol":"24.69"},{"date":"2019-12-31","value":"19.26","vol":"25.45"},{"date":"2019-09-30","value":"20.52","vol":"25.95"},{"date":"2019-06-30","value":"21.09","vol":"26.89"},{"date":"2019-03-31","value":"23.59","vol":"26.43"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.64 | 19.26 | 20.52 | 21.09 | 23.59 |
| 行业(%) | 24.69 | 25.45 | 25.95 | 26.89 | 26.43 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.27","vol":"0.59"},{"date":"2019-12-31","value":"0.28","vol":"0.62"},{"date":"2019-09-30","value":"0.30","vol":"0.39"},{"date":"2019-06-30","value":"0.31","vol":"0.41"},{"date":"2019-03-31","value":"0.35","vol":"0.42"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.27 | 0.28 | 0.30 | 0.31 | 0.35 |
| 行业(%) | 0.59 | 0.62 | 0.39 | 0.41 | 0.42 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 天风证券 | 2020-05-13 | 买入 | 买入 |
| 华西证券 | 2020-05-12 | 买入 | 买入 |
| 国盛证券 | 2020-05-12 | 买入 | 买入 |
| 广发证券 | 2020-05-05 | 买入 | 买入 |
| 中银证券 | 2020-04-25 | 增持 | |
| 上海证券 | 2020-03-25 | 增持 | 增持 |
机构预测
机构预测该股2020年每股收益与前一年相同，长期投资价值一般。
[{"date":"2016","yellowRectValue":"0.70","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"-5.37","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"10.46","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.42","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"9.33","blueLineValue":"0.61","type":"YC"}]